Apnimed APMD Estimates

NASDAQ APMD
$15.06 -0.34 (-2.21%)
At close: Nov 3, 2026 · 4:00 PM EST
Analyst Estimates

Apnimed, Inc. Quarterly Revenue Estimates

Periods 6
Next Period Q3 26
Consensus 0.00

Analysts expect Apnimed, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 12.08 M.

Metric Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 84.80 M12.08 M----
High Estimate -0.000.000.000.00560,656.40
Low Estimate -0.000.000.000.00460,883.60
Consensus Estimate -0.000.000.000.00510,770.00
Analyst Estimates

Apnimed, Inc. Quarterly Earnings Per Share (EPS) Estimates

Periods 6
Next Period Q3 26
Consensus -0.68

Analysts expect Apnimed, Inc. to report earnings per share of -0.68 for Q3 26, against a range of -0.73 to -0.63. The most recent reported quarter, Q2 26, came in at 3.92, a 853.8% beat against the -0.52 consensus.

Metric Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 2.143.92----
High Estimate --0.50-0.63-0.81-1.05-1.12
Low Estimate --0.54-0.73-0.87-1.13-1.34
Consensus Estimate --0.52-0.68-0.84-1.09-1.23

Apnimed, Inc. Estimates API

Pull Wall Street consensus for Apnimed, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=APMD&mode=revenue&api_key=YOUR_API_KEY